Abstract:In this paper, we have handpicked 23 kinds of electronic properties, 37 kinds of steric properties, 54 kinds of hydrophobic properties and 5 kinds of hydrogen bond properties from thousands of amino acid structural and property parameters. Principal component analysis (PCA) was applied on these parameters and thus ten score vectors involving significant nonbonding properties of 20 coded amino acids were yielded, called the divided physicochemical property scores (DPPS) of amino acids. The DPPS descriptor was then used to characterize the structures of 152 HLA-A*0201-restricted CTL epitopes, and significant variables being responsible for the binding affinities were selected by genetic algorithm, and a quantitative structure–activity relationship (QSAR) model by partial least square was established to predict the peptide-HLA-A*0201 molecule interactions. Statistical analysis on the resulted DPPS-based QSAR models were consistent well with experimental exhibits and molecular graphics display. Diversified properties of the different residues in binding peptides may contribute remarkable effect to the interactions between the HLA-A*0201 molecule and its peptide ligands. Particularly, hydrophobicity and hydrogen bond of anchor residues of peptides may have a significant contribution to the interactions. The results showed that DPPS can well represent the structural characteristics of the antigenic peptides and is a promising approach to predict the affinities of peptide binding to HLA-A*0201 in a efficient and intuitive way. We expect that this physical-principle based method can be applied to other protein–peptide interactions as well.

Applying Generalized Hydrophobicity Scale of Amino Acids to Quantitative Prediction of Human Leukocyte Antigen-A*0201-restricted Cytotoxic T Lymphocyte Epitope

Prediction of HLA-A*0201 Restricted Cytotoxic T Lymphocyte Epitopes Based on High-Dimensional Descriptor Nonlinear Screening

Identification of predicted epitopes of HLA-A * 0201-restricted cytotoxic T lymphocytes derived from human papillomavirus type 11 E7 antigen

In Silico Quantitative Prediction of Peptides Binding Affinity to Human MHC Molecule: an Intuitive Quantitative Structure–activity Relationship Approach

A Structure‐based, Quantitative Structure–Activity Relationship Approach for Predicting HLA‐A*0201‐restricted Cytotoxic T Lymphocyte Epitopes

A Novel Method to Estimate the Affinity of HLA-A∗0201 Restricted CTL Epitope

Study On Quantitative Structure-Activity Relationships Of Hla-A*0201 Restrictive Ctl Epitopes

A Rapid Method for Quantitative Prediction of High Affinity CTL Epitopes: QSAR Studies on Peptides Having Affinity with the Class I MHC Molecular HLA-A*0201

Toward the Quantitative Prediction of T-Cell Epitopes: QSAR Studies on Peptides Having Affinity with the Class I MHC Molecular HLA-A*0201.

A New Set of Amino Acid Descriptors for the Development of Quantitative Sequence‐Activity Modelings of HLA‐A*0201 Restrictive CTL Epitopes

Estimation of affinity of HLA-A*0201 restricted CTL epitope based on the SCORE function.

Molecular Field Analysis on HLA-A*0201 Restricted CTL Epitope

3D-Qsar Study on the Hla-A*0201 Restricted Ctl Epitope

A set of new amino acid descriptors applied in prediction of MHC class I binding peptides.

Estimation of the Affinity of HLA-A*0201 Restricted CTL Epitope Based on SCORE Function

Toward prediction of binding affinities between the MHC protein and its peptide ligands using quantitative structure-affinity relationship approach.

Predicting the affinity of epitope-peptides with class I MHC molecule HLA-A*0201: an application of amino acid-based peptide prediction.

QSAR study on MHC class I a alleles based on the novel parameters of amino acids.

Prediction and Identification of HLA-A2 Restricted CTL Epitope Derived from the Leukemia-Associated Antigen MLAA-34

Prediction and Identification of HLA-A*0201-restricted Epitopes from Leukemia-Associated Protein MLAA-22 Which Elicit Cytotoxic T Lymphocytes

Prediction and Peptide Binding Analysis of HLA-A*0201-restricted CTL Epitope from MUC4